CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 1
- ScaleRevenue is $3.37M, lower than 95% of all stocks globally
- FinancialsLow earnings quality
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.29BUSDvs all stocks (USD)
Revenue (TTM)
3.37MUSDvs all stocks (USD)
Beta
1.24xvs all stocks
52-Week Change
-28.75%vs all stocks
Market Capitalization
1.29BUSDvs all stocks (USD)
Enterprise Value
1.06BUSDvs all stocks (USD)
Forward P/E
-16.37xPrice to Book (MRQ)
2.38xEnterprise to Revenue
314.35xEnterprise to EBITDA
-9.73xGross Margin
58.86%Operating Margin
-3259.56%Return on Assets (TTM)
-14.19%Return on Equity (TTM)
-2.21%Revenue (TTM)
3.37MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.0240USDUpdated Jul 19, 2026Quarterly Revenue Growth
16.70%Gross Profit (TTM)
2.18MUSDvs all stocks (USD)
EBITDA (TTM)
-108.79MUSDvs all stocks (USD)
Net Income (TTM)
-33.62MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
16.73%Operating Cash Flow (TTM)
-106.04MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-59.18MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
7.46MUSDFY2025 · Dec 31, 2025Revenue
3.24MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.13MUSDFY2025 · Dec 31, 2025Gross Profit
2.12MUSDFY2025 · Dec 31, 2025Operating Income
-111.02MUSDvs all stocks (USD)
Pre-tax Income
-125.03MUSDFY2025 · Dec 31, 2025Income Tax Expense
12.00KUSDFY2025 · Dec 31, 2025Net Income
-125.05MUSDFY2025 · Dec 31, 2025EBIT
-120.89MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-114.83MUSDFY2025 · Dec 31, 2025Research & Development
275.00KUSDFY2025 · Dec 31, 2025Selling, General & Administrative
39.27MUSDFY2025 · Dec 31, 2025Other Operating Expenses
63.29MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
4.14MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.7900USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.7900USDFY2025 · Dec 31, 2025Basic Shares Outstanding
133.58MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
133.58MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-125.05MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
19.17MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-108.55MUSDFY2025 · Dec 31, 2025Free Cash Flow
-113.66MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
173.26MUSDFY2025 · Dec 31, 2025Income Tax Paid
29.00KUSDFY2025 · Dec 31, 2025Interest Paid
3.53MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-125.05MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
2.95MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
0.00USDFY2025 · Dec 31, 2025Stock-based Compensation
11.66MUSDFY2025 · Dec 31, 2025Other Non-cash Items
4.33MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.04MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.48MUSDFY2025 · Dec 31, 2025Capital Expenditures
-5.11MUSDFY2025 · Dec 31, 2025Net Acquisitions
9.70MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
4.59MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
5.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-46.24MUSDFY2025 · Dec 31, 2025Other Financing Charges
18.87MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
208.75MUSDFY2025 · Dec 31, 2025Shares Outstanding
157.99MSharesUpdated Jul 19, 2026Float Shares
125.96MSharesUpdated Jul 19, 2026Shares Short
10.14MSharesUpdated Jul 19, 2026Short Ratio
3.91daysvs all stocks
Short % of Shares Outstanding
8.14%vs all stocks
% Held by Insiders
19.73%vs all stocks
% Held by Institutions
77.33%vs all stocks
Total Cash (MRQ)
289.82MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.83USDUpdated Jul 19, 2026Total Debt (MRQ)
35.37MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0648xCurrent Ratio (MRQ)
6.25xBook Value per Share (MRQ)
3.42USDUpdated Jul 19, 2026Total Assets
483.27MUSDvs all stocks (USD)
Total Current Assets
180.19MUSDFY2025 · Dec 31, 2025Total Liabilities
59.70MUSDFY2025 · Dec 31, 2025Total Non-current Assets
303.08MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
5.83MUSDFY2025 · Dec 31, 2025Total Current Liabilities
53.88MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
173.26MUSDFY2025 · Dec 31, 2025Accounts Receivable
14.00KUSDFY2025 · Dec 31, 2025Accounts Payable
7.79MUSDFY2025 · Dec 31, 2025Short-term Debt
34.82MUSDFY2025 · Dec 31, 2025Deferred Revenue
2.75MUSDFY2025 · Dec 31, 2025Long-term Debt
1.08MUSDFY2025 · Dec 31, 2025Common Stock (Book)
15.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-636.00MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
423.57MUSDvs all stocks (USD)
52-Week Low
7.90USDUpdated Jul 19, 202652-Week High
21.55USDUpdated Jul 19, 202652-Week Change
-28.75%vs all stocks
Beta
1.24xvs all stocks
50-Day MA
11.44USDUpdated Jul 19, 2026200-Day MA
13.89USDUpdated Jul 19, 2026Avg 10-Day Volume
2.03MSharesUpdated Jul 19, 2026Avg 30-Day Volume
2.41MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-0.2900USDUpdated Jul 19, 2026Other Income / Expense
-9.88MUSDFY2025 · Dec 31, 20255 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.69
Altman Z-Score 10.59: safe zoneNotable
Altman Z-Score: 10.59
Supply Chain
Upstream position: supplies 6 industries, depends on 1Notable
Outgoing: 6.00Incoming: 1.00
Scale
Revenue is $3.37M, lower than 95% of all stocks globallySignificant
Revenue (USD): 3,367,000Global P5: 30,274,777.221
Market cap is $1.29B, above the global median of $1.15BNotable
Market cap (USD): 1,286,910,651Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Oriental Energy Co. Ltd.
Tier 1ProductionDepleting ExtractiveRuleRisk
Alkane Resources Limited
Tier 1ProductionDepleting ExtractiveFlowRisk
Americas Gold and Silver Corporation
Tier 1ProductionDepleting ExtractiveFlowRisk
Alphamin Resources Corporation
Tier 1ProductionDepleting ExtractiveFlowRisk
Shanghai Datun Energy Co., Ltd.
Tier 1ProductionDepleting ExtractiveFlowRisk
Ora Banda Mining Limited
Tier 1ProductionDepleting ExtractiveFlowRisk
Huludao Zinc Industry Co. Ltd.
Tier 1ProductionDepleting ExtractiveFlowRisk
Arizona Sonoran Copper Company Inc.
Tier 1ProductionDepleting ExtractiveRiskRule
Hemlo Mining Corp.
Tier 1ProductionDepleting ExtractiveFlowRisk
Cvk Maden Isletmeleri Sanayi A.S.
Tier 1ProductionDepleting ExtractiveFlowRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Fulcrum Therapeutics Inc.
5 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedCash Elevated Relative to Current Liabilities and Total AssetsDecline With Range Expansion And DrawdownLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Mueller Industries Inc.
5 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedCash Elevated Relative to Current Liabilities and Total AssetsDecline With Range Expansion And DrawdownLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Nano Nuclear Energy Inc.
5 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedCash Elevated Relative to Current Liabilities and Total AssetsDecline With Range Expansion And DrawdownLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration